Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan

expressbpdJune 27, 2019

Tag: AbbVie , Humira , Botox-maker

PharmaSources Customer Service